ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,203Medicare Part D Prescriptions Filled, Including Refills

Rank: 145 out of 1206

$546K Total Retail Price of All Prescriptions

Rank: 129 out of 1206

419 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
40% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 419 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

11% of this provider’s 419 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 10,145 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $46 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
LEVOTHYROXINE SODIUM 604 553 1 2
FUROSEMIDE 534 510 2 5
OMEPRAZOLE 375 365 3 3
LISINOPRIL 369 332 4 4
METOPROLOL SUCCINATE 335 327 5 15
CRESTOR 303 263 6 30
AMLODIPINE BESYLATE 290 270 7 6
WARFARIN SODIUM 270 260 8 8
HYDROCHLOROTHIAZIDE 265 257 9 11
METOPROLOL TARTRATE 247 218 10 9
POTASSIUM CHLORIDE 246 229 11 12
SIMVASTATIN 217 211 12 1
NAMENDA 203 203 13 36
ATORVASTATIN CALCIUM 179 177 14 13
CITALOPRAM HBR 179 163 14 16
HYDROCODONE-ACETAMINOPHEN 179 154 S3 14 7
GABAPENTIN 176 132 17 18
SERTRALINE HCL 173 161 18 22
POLYETHYLENE GLYCOL 3350 165 137 19 31
DIOVAN 164 157 20 57
METFORMIN HCL 152 131 21 10
LANTUS SOLOSTAR 150 150 22 85
DONEPEZIL HCL 123 123 23 29
QUETIAPINE FUMARATE 118 117 24 79
PREDNISONE 114 111 25 28
PANTOPRAZOLE SODIUM 104 101 26 54
ALBUTEROL SULFATE 103 103 27 123
FAMOTIDINE 103 84 27 65
ATENOLOL 102 90 29 14
ALENDRONATE SODIUM 98 91 30 19
DIGOXIN 97 97 31 43
ALLOPURINOL 88 77 32 24
ZOLPIDEM TARTRATE 79 71 33 25
RAMIPRIL 75 75 34 96
DIOVAN HCT 68 58 35 112
MUPIROCIN 65 40 36 185
TRAMADOL HCL 62 55 37 17
LEVOFLOXACIN 61 58 38 78
ISOSORBIDE MONONITRATE ER 59 59 39 40
CYMBALTA 58 51 40 63
MORPHINE SULFATE ER 56 56 S2 41 114
PEN NEEDLE 54 47 42 121
DILTIAZEM 24HR CD 54 54 42 67
FLUOXETINE HCL 54 51 42 52
RANITIDINE HCL 53 45 45 23
PLAVIX 52 42 46 72
TAMSULOSIN HCL 51 51 47 26
CLOPIDOGREL 51 46 47 48
FENTANYL 51 49 S2 47 51
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 17, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.